• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-4通过激活雄激素受体和Akt信号通路增强前列腺特异性抗原的表达。

Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.

作者信息

Lee Soo Ok, Lou Wei, Hou Min, Onate Sergio A, Gao Allen C

机构信息

Department of Medicine and Pharmacology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

出版信息

Oncogene. 2003 Sep 11;22(39):7981-8. doi: 10.1038/sj.onc.1206735.

DOI:10.1038/sj.onc.1206735
PMID:12970746
Abstract

Androgen receptor (AR) plays an important role in the development and progression of prostate cancer upon the action of androgen through the binding of the androgen-responsive elements (AREs) on the target genes. Abnormal activation of the AR by nonandrogen has been implicated in the progression of androgen-independent prostate cancer. The levels of interleukin-4 (IL-4) are significantly elevated in sera of patients with hormone refractory prostate cancer. The potential role of IL-4 on the activation of AR was investigated in prostate cancer cells. IL-4 enhances AR-mediated prostate-specific antigen (PSA) expression and ARE-containing gene activity through activation of the AR in the androgen ablation condition in human prostate cancer cells. The AR can also be sensitized by IL-4 and activated by significantly lower levels of androgen (10 pM of R1881) in prostate cancer cells. IL-4 enhances nuclear translocation of AR and increases binding of the AR to the ARE in LNCaP prostate cancer cells. Blocking of the Akt pathway by an Akt-specific inhibitor LY294002 abrogates IL-4-induced PSA expression and AR signaling. These results demonstrate that IL-4 enhances PSA expression through activation of the AR and Akt signaling pathways in LNCaP prostate cancer cells. Understanding IL-4-induced signaling leading to abnormal activation of AR will provide insights into the molecular mechanisms of androgen-independent progression of prostate cancer cells.

摘要

雄激素受体(AR)在雄激素作用下,通过与靶基因上的雄激素反应元件(AREs)结合,在前列腺癌的发生和发展中发挥重要作用。非雄激素对AR的异常激活与去势抵抗性前列腺癌的进展有关。激素难治性前列腺癌患者血清中白细胞介素-4(IL-4)水平显著升高。研究了IL-4在前列腺癌细胞中对AR激活的潜在作用。在人前列腺癌细胞的雄激素剥夺条件下,IL-4通过激活AR增强AR介导的前列腺特异性抗原(PSA)表达和含ARE基因的活性。在前列腺癌细胞中,IL-4还可使AR敏感,并被显著较低水平的雄激素(10 pM的R1881)激活。IL-4增强LNCaP前列腺癌细胞中AR的核转位,并增加AR与ARE的结合。用Akt特异性抑制剂LY294002阻断Akt通路可消除IL-4诱导的PSA表达和AR信号传导。这些结果表明,IL-4通过激活LNCaP前列腺癌细胞中的AR和Akt信号通路增强PSA表达。了解IL-4诱导的导致AR异常激活的信号传导将为前列腺癌细胞去势抵抗进展的分子机制提供见解。

相似文献

1
Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.白细胞介素-4通过激活雄激素受体和Akt信号通路增强前列腺特异性抗原的表达。
Oncogene. 2003 Sep 11;22(39):7981-8. doi: 10.1038/sj.onc.1206735.
2
Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.青蒿素通过刺激26S蛋白酶体介导的雄激素受体蛋白降解,破坏人前列腺癌细胞的雄激素反应性。
Anticancer Drugs. 2017 Oct;28(9):1018-1031. doi: 10.1097/CAD.0000000000000547.
3
Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.核因子-κB在白细胞介素-4诱导前列腺癌细胞雄激素受体激活中的作用
Prostate. 2005 Jul 1;64(2):160-7. doi: 10.1002/pros.20218.
4
Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.雄激素诱导 PSA 表达不仅需要 AR 的激活,还需要人前列腺癌细胞中内源性 IGF-I 或 IGF-I/PI3K/Akt 信号通路。
Prostate. 2011 May 15;71(7):766-77. doi: 10.1002/pros.21293. Epub 2010 Oct 28.
5
Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.磷脂酰肌醇3激酶/蛋白激酶B下游底物FOXO3a诱导雄激素受体表达及其在LNCaP前列腺癌细胞凋亡中的作用。
J Biol Chem. 2005 Sep 30;280(39):33558-65. doi: 10.1074/jbc.M504461200. Epub 2005 Aug 1.
6
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.雄激素依赖性和非依赖性前列腺癌细胞增殖中的信号转导通路
Endocr Relat Cancer. 2005 Mar;12(1):119-34. doi: 10.1677/erc.1.00835.
7
Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.白细胞介素6通过信号转导和转录激活因子3依赖性途径激活LNCaP前列腺癌细胞中雄激素受体介导的基因表达。
Cancer Res. 2000 Apr 15;60(8):2132-5.
8
Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.前列腺癌中的生长激素(GH)受体:在人体组织和细胞系中的基因表达及特性、LNCaP细胞中的GH信号传导与雄激素受体调控
Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23. doi: 10.1016/j.mce.2004.03.004.
9
Androgen receptor signaling: mechanism of interleukin-6 inhibition.雄激素受体信号传导:白细胞介素-6抑制机制
Cancer Res. 2004 Apr 1;64(7):2619-26. doi: 10.1158/0008-5472.can-03-3486.
10
Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.长期雄激素去除会导致前列腺癌细胞对PI3K/Akt信号通路抑制的抗性增加。
Prostate. 2004 Feb 15;58(3):259-68. doi: 10.1002/pros.10332.

引用本文的文献

1
Causal association of peripheral immune cell counts with risk of prostate cancer: insights from bidirectional Mendelian randomization.外周免疫细胞计数与前列腺癌风险的因果关联:双向孟德尔随机化研究的见解
Front Oncol. 2024 Nov 29;14:1374927. doi: 10.3389/fonc.2024.1374927. eCollection 2024.
2
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist.炎症通过白细胞介素 1 受体拮抗剂影响前列腺基底干细胞中的雄激素受体信号转导。
Commun Biol. 2024 Oct 25;7(1):1390. doi: 10.1038/s42003-024-07071-y.
3
The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
促炎细胞因子和 CXC 趋化因子(CXCL1-CXCL16)在前列腺癌进展中的作用:对其治疗管理的深入了解。
Cell Mol Biol Lett. 2024 May 14;29(1):73. doi: 10.1186/s11658-024-00591-9.
4
Inflammation Impacts Androgen Receptor Signaling in Basal Prostate Stem Cells Through Interleukin 1 Receptor Antagonist.炎症通过白细胞介素1受体拮抗剂影响前列腺基底干细胞中的雄激素受体信号传导。
Res Sq. 2023 Dec 15:rs.3.rs-3539806. doi: 10.21203/rs.3.rs-3539806/v1.
5
A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk.多基因panel 研究鉴定出与前列腺癌风险相关的单核苷酸多态性。
Int J Mol Sci. 2023 Apr 20;24(8):7594. doi: 10.3390/ijms24087594.
6
Editorial Expression of Concern: Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.关注编辑声明:白细胞介素-4通过激活雄激素受体和Akt信号通路增强前列腺特异性抗原的表达。
Oncogene. 2021 Nov;40(47):6547. doi: 10.1038/s41388-021-02034-7.
7
Interactions with Muscle Cells Boost Fusion, Stemness, and Drug Resistance of Prostate Cancer Cells.与肌肉细胞的相互作用可增强前列腺癌细胞的融合、干性和耐药性。
Mol Cancer Res. 2019 Mar;17(3):806-820. doi: 10.1158/1541-7786.MCR-18-0500. Epub 2018 Dec 26.
8
Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival.12型腺病毒E1A对雄激素受体反式激活功能的抑制作用会破坏前列腺癌细胞的存活。
Prostate. 2018 Nov;78(15):1140-1156. doi: 10.1002/pros.23689. Epub 2018 Jul 15.
9
Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.IL4、MGMT 和 AKT1 中的种系变异与前列腺癌特异性死亡率相关:对 12082 例前列腺癌病例的分析。
Prostate Cancer Prostatic Dis. 2018 Jun;21(2):228-237. doi: 10.1038/s41391-017-0029-2. Epub 2018 Jan 3.
10
Associations between polymorphisms in the IL-4 and IL-4 receptor genes and urinary carcinomas: a meta-analysis.白细胞介素-4及白细胞介素-4受体基因多态性与尿路上皮癌的相关性:一项荟萃分析
Int J Clin Exp Med. 2015 Jan 15;8(1):1227-33. eCollection 2015.